CPHI Stock Analysis: Buy, Sell, or Hold?
CPHI - China Pharma Holdings, Inc.
$1.13
-0.01 (-1.32%)
▼
5d:
-13.46%
30d:
+64.79%
90d:
+118.4%
WAIT
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 13, 2026
8d
Get Alerted When CPHI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CPHI is down 13.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CPHI is down 13.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CPHI is currently trading at $1.12, which is considered fair relative to its 30-day fair value range of $-0.14 to $2.64.
Technical Outlook: Technically, CPHI is showing sideways momentum. Immediate support is located at $0.81, while resistance sits at $19.19.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+163.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CPHI is showing sideways momentum. Immediate support is located at $0.81, while resistance sits at $19.19.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+163.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$-0.14 -
$2.64
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 163.2% below Wall St target ($3.00)
- WARNING: Recommendation downgraded due to -13.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$-0.14 -
$2.64
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.81
Resistance Level
$19.19
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.56
Wall Street Target
$3.00
(+163.2%)
Revenue Growth (YoY)
-13.4%
Profit Margin
-88.8%
Share & Embed Analysis
Last updated: August 04, 2026 11:09 AM ET
Data refreshes hourly during market hours. Next update: 12:09 PM
Data refreshes hourly during market hours. Next update: 12:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CPHI showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 58 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 49 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 46 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
